Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Choong Mo Kang

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Imaging and Biology|April 15, 2017
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical EvaluationZhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald, et al.
Molecular Pharmaceutics|October 18, 2023
Porphyrin-Based Brain Tumor-Targeting Agents: [<sup>64</sup>Cu]Cu-porphyrin and [<sup>64</sup>Cu]Cu-TDAPChangkeun Im, Jae Hun Ahn, Ahmed K Farag, et al.
Nuclear Medicine and Biology|March 13, 2012
Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPETIljung Lee, Kwang Yup Yoon, Choong Mo Kang, et al.
Nuclear Medicine and Biology|February 18, 2021
Synthesis and preliminary evaluation of <sup>211</sup>At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancerGanesan Vaidyanathan, Ronnie C Mease, Il Minn, et al.
Amino Acids|April 22, 2016
Catabolism of (64)Cu and Cy5.5-labeled human serum albumin in a tumor xenograft modelChoong Mo Kang, Hyunjung Kim, Hyun-Jung Koo, et al.
Journal of Drug Targeting|November 14, 2013
Characterization of oleanolic acid derivative for colon cancer targeting with positron emission tomographySung-Min Kim, Il Ha Jeong, Min Su Yim, et al.
Chemical Communications (Cambridge, England)|July 16, 2011
Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platformTae-Lin Ha, Hyo Jin Kim, Jongmin Shin, et al.
Journal of Breast Cancer|February 8, 2022
The Prediction of HER2-Targeted Treatment Response Using <sup>64</sup>Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case ReportInki Lee, Ilhan Lim, Byung Hyun Byun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-TherapyRonnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Bioconjugate Chemistry|February 11, 2014
Tumor-homing glycol chitosan-based optical/PET dual imaging nanoprobe for cancer diagnosisSangmin Lee, Sun-Woong Kang, Ju Hee Ryu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Imaging and Biology|April 15, 2017
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical EvaluationZhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald, et al.
Molecular Pharmaceutics|October 18, 2023
Porphyrin-Based Brain Tumor-Targeting Agents: [<sup>64</sup>Cu]Cu-porphyrin and [<sup>64</sup>Cu]Cu-TDAPChangkeun Im, Jae Hun Ahn, Ahmed K Farag, et al.
Nuclear Medicine and Biology|March 13, 2012
Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPETIljung Lee, Kwang Yup Yoon, Choong Mo Kang, et al.
Nuclear Medicine and Biology|February 18, 2021
Synthesis and preliminary evaluation of <sup>211</sup>At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancerGanesan Vaidyanathan, Ronnie C Mease, Il Minn, et al.
Amino Acids|April 22, 2016
Catabolism of (64)Cu and Cy5.5-labeled human serum albumin in a tumor xenograft modelChoong Mo Kang, Hyunjung Kim, Hyun-Jung Koo, et al.
Journal of Drug Targeting|November 14, 2013
Characterization of oleanolic acid derivative for colon cancer targeting with positron emission tomographySung-Min Kim, Il Ha Jeong, Min Su Yim, et al.
Chemical Communications (Cambridge, England)|July 16, 2011
Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platformTae-Lin Ha, Hyo Jin Kim, Jongmin Shin, et al.
Journal of Breast Cancer|February 8, 2022
The Prediction of HER2-Targeted Treatment Response Using <sup>64</sup>Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case ReportInki Lee, Ilhan Lim, Byung Hyun Byun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-TherapyRonnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Bioconjugate Chemistry|February 11, 2014
Tumor-homing glycol chitosan-based optical/PET dual imaging nanoprobe for cancer diagnosisSangmin Lee, Sun-Woong Kang, Ju Hee Ryu, et al.
Pageof 4